Question 1

What's the Glenmark Pharmaceuticals Ltd share price today?

Accepted Answer

Glenmark Pharmaceuticals Ltd share price was Rs 2,000.60 at close on 16th Jan 2026. Glenmark Pharmaceuticals Ltd share price was up by 52.23% over the previous closing price of Rs 1,314.20. Glenmark Pharmaceuticals Ltd share price trend:

Last 1 Month: Glenmark Pharmaceuticals Ltd share price moved up by 360.44% on BSE
Last 3 Months: Glenmark Pharmaceuticals Ltd share price moved up by 373.29% on BSE
Last 12 Months: Glenmark Pharmaceuticals Ltd share price moved up by 303.43% on BSE
Last 3 Years: Glenmark Pharmaceuticals Ltd price moved up by 566.09% on BSE

Question 2

How can I quickly analyse the performance of the Glenmark Pharmaceuticals Ltd stock?

Accepted Answer

The performance of the Glenmark Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:

The stock's PE is 55.91
Price to book value ratio is 5.89
Dividend yield of 0.12
The EPS (trailing 12 months) of the Glenmark Pharmaceuticals Ltd stock is Rs 35.78

Question 3

What is the market cap of Glenmark Pharmaceuticals Ltd?

Accepted Answer

Glenmark Pharmaceuticals Ltd has a market capitalisation of Rs 56,457 crore.

Question 4

What is Glenmark Pharmaceuticals Ltd's 52-week high/low share price?

Accepted Answer

The Glenmark Pharmaceuticals Ltd’s 52-week high share price is Rs 2,286.15 and 52-week low share price is Rs 1,274.70.

Question 5

Is the Glenmark Pharmaceuticals Ltd profitable?

Accepted Answer

On a consolidated basis, Glenmark Pharmaceuticals Ltd reported a profit of Rs 348.03 crore on a total income of Rs 3,418.68 crore for the quarter ended 2024. For the year ended Dec 2024, Glenmark Pharmaceuticals Ltd had posted a profit of Rs 348.03 crore on a total income of Rs 3,418.68 crore.

Question 6

Which are Glenmark Pharmaceuticals Ltd’s peers in the Health care sector?

Accepted Answer

Glenmark Pharmaceuticals Ltd’s top 5 peers in the Health care sector are  Aurobindo Pharma, Abbott India, Laurus Labs, Glenmark Pharma., Biocon, Glaxosmi. Pharma, Ipca Labs..

Question 7

Who owns how much in Glenmark Pharmaceuticals Ltd?

Accepted Answer

Key changes to the Glenmark Pharmaceuticals Ltd shareholding are as follows:

Promoter holding in Glenmark Pharmaceuticals Ltd has gone up to 46.65 per cent as of Dec 2022 from 46.65 per cent as of Mar 2022.
Foreign Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 23.20 per cent as of Dec 2022 from 24.12 per cent as of Mar 2022.
Indian Public holding in Glenmark Pharmaceuticals Ltd has gone up to 16.72 per cent as of Dec 2022 from 15.88 per cent as of Mar 2022.
Mutual Funds Uti holding in Glenmark Pharmaceuticals Ltd has gone down to 5.64 per cent as of Dec 2022 from 6.18 per cent as of Mar 2022.
Insurance Companies holding in Glenmark Pharmaceuticals Ltd has gone up to 4.48 per cent as of Dec 2022 from 0.00 per cent as of Mar 2022.
Non Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone up to 2.71 per cent as of Dec 2022 from 2.39 per cent as of Mar 2022.
Other Institutional Investors holding in Glenmark Pharmaceuticals Ltd has gone down to 0.41 per cent as of Dec 2022 from 4.34 per cent as of Mar 2022.
Financial Institutions holding in Glenmark Pharmaceuticals Ltd has gone down to 0.20 per cent as of Dec 2022 from 0.44 per cent as of Mar 2022.
Custodians holding in Glenmark Pharmaceuticals Ltd has gone up to 0.00 per cent as of Dec 2022 from 0.00 per cent as of Mar 2022.

Market Cap (₹ Cr)	56,457
Traded Value (₹ Cr)	2.79
Volume (Shares)	13,931
Face Value (₹)	1

52-Week High (₹)	2,286.15
52-Week High Date	11-Jul-2025
52-Week Low (₹)	1,274.70
52-Week Low Date	28-Feb-2025

All Time High (₹)	2,286.15
All Time High Date	11-Jul-2025
All Time Low (₹)	1.89
All Time Low Date	10-Feb-2000

Glenmark Pharmaceuticals Share Price

Glenmark Pharmaceuticals Ltd